Ferrer Internacional SA engages in the development, manufacture and commercialization of pharmaceutical products for the diagnosis and treatment of cardiovascular, dermatological, gastrointestinal and respiratory conditions. It also designs and produces active ingredients and nutraceuticals for the food, cosmetics and animal feed industries. The company was founded on April 17, 1940 and is headquartered in Barcelona, Spain.

Biocodex SA develops and markets pharmaceutical products. Its services include Gastroentorology, Neurology and Psychiatry, pain treatment, and degenerative Osteoarthritis treatment. The company was founded in 1953 and is headquartered in Gentilly, France.

XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. Horizant® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in the United States by XenoPort. Regnite® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in Japan by Astellas Pharma Inc. XenoPort holds all other world-wide rights to gabapentin enacarbil. XenoPort's pipeline of product candidates includes potential treatments for patients with Parkinson's disease, relapsing-remitting multiple sclerosis and psoriasis.

Teikoku Pharma USA, Inc. develops and manufactures drugs. It provides patches, unit-dose jellies and liquids, creams, ointments, and other delivery products for pain management and cosmetic care. The company was founded by Masahisa Kitagawa and Ichiro Mori in 1997 and is headquartered in San Jose, CA.

Desitin Arzneimittel manufactures the majority of sophisticated products for the therapy of neurological and psychiatric diseases. They offer training courses and scientific information for doctors and pharmacists to support them in the sophisticated treatment of neurological diseases. They offer patients therapy-accompanying services to support the safe and reliable use of their medicines in various life situations and to promote adherence to therapy.

Alla Chem LLC is an American private company located in Hallandale Beach, FL, specializing in pharmaceutical preparations. It was founded in 2004.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

USB LTD. is a private company headquartered in the United Kingdom providing investment services.

Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Pharnext is an advanced clinical-stage biopharmaceutical company founded in April 2007 by renowned scientists and entrepreneurs including Professor Daniel Cohen and collaborators, pioneers in modern genomics. The company develops new therapeutics for neurodegenerative diseases - orphan and common – where there are currently no cures and existing therapies available. Pharnext is the pioneer of a new paradigm for the discovery of medicinal drugs: PLEOTHERAPY™. The R&D approach protected by Pharnext systemizes new uses of approved drugs. It is based on network pharmacology utilizing complex and extensive genomic data to identify the thousands of molecules possibly involved in a disease. From this disease molecular network, Pharnext deduces synergistic combinations of drugs already approved but for unrelated indications. These novel therapeutics called PLEODRUG™ are then developed at new optimal doses and under new formulations. They offer several key advantages: efficacy, safety, and intellectual property including several composition of matter patents already granted. The proof of concept of the PLEOTHERAPY approach was obtained with PLEODRUG PXT3003 in Charcot-Marie-Tooth disease type 1A (CMT1A) through positive and consistent Phase 2 and Phase 3 results. PLEODRUG PXT864 generated encouraging Phase 2 data in Alzheimer’s disease. They also plan to develop the same agent in other orphan and common neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis (ALS).

Lohocla is a research and development company that is at the forefront of discovery bioscience center photoof medications for chronic pain, addictive and other mental health and neurological disorders. Lohocla is also unique in its dedication to developing biological markers (diagnostics) that aid the physician in properly allocating Lohocla-developed medications to the appropriate patients. The tenets of personalized medicine drive the company’s research efforts.

Medical research

The Ernest Gallo Clinic and Research Center (Gallo Center) at the University of California, San Francisco (UCSF) was established in 1980 to study basic neuroscience and the effects of alcohol and drugs of abuse on the brain. It is the only center studying alcoholism in the United States that is based in a department of neurology. Since its inception, The Gallo Center has major neuroscience laboratories in cell biology, molecular biology, biochemistry,pharmacology,neurophysiology, behavioralpharmacology and physiology, and ivertebrate, mouse and human genetics.

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Hangzhou Biqun Pharmaceutical Technology Co., Ltd., established on 2015-05-15, Business scope includes services:Pharmaceutical Intermediates,biomedicine,medical instruments,medical technology,technology development in biotechnology,Technical Services,technical consulting,Achievement transfer,Intellectual Property Consulting(depatent);wholesale,retail:Pharmaceutical Intermediates(Removal of hazardous chemicals and precursor chemicals),Computer hardware and software,Chemical raw materials(Removal of hazardous chemicals and precursor chemicals),Instrumentation,Equipment;All other legal items that do not need to be submitted for approval.

Sichuan Jianteng Biotechnology Co., Ltd., established on 2016-12-15, Business scope includes raw materials,Drug Injection,tablet,Capsules,Granules,pill,Development of freeze-dried powder injection,Production,Sales(Items subject to approval by law,the term,Subject to the approval of the drug production license);Pharmaceutical and chemical intermediates(Free of Hazardous Chemicals,monitor,precursor chemicals),Biological product(Free of Hazardous Chemicals,monitor,precursor chemicals),Food and Food Additives,Feed and Feed Additives,Research and development of daily chemical products,Production,Sales;Extraction and separation of animal and plant active ingredients;Transfer of technological achievements and related technical services;agricultural products,Planting of Chinese herbal medicines,buy,processing,Sales;Import and export of goods and technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)